Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Skin microbiome and dermatologic disorders
Tiffany C. Scharschmidt, Julia A. Segre
Tiffany C. Scharschmidt, Julia A. Segre
Published February 3, 2025
Citation Information: J Clin Invest. 2025;135(3):e184315. https://doi.org/10.1172/JCI184315.
View: Text | PDF
Review Series

Skin microbiome and dermatologic disorders

  • Text
  • PDF
Abstract

Human skin acts as a physical barrier to prevent the entry of pathogenic microbes while simultaneously providing a home for commensal bacteria and fungi. Microbiome sequencing studies have demonstrated the unappreciated diversity and selectivity of these microbes. Functional studies have demonstrated the impact of specific strains to tune the immune system, sculpt the microbial community, provide colonization resistance, and promote epidermal barrier integrity. Recent studies have integrated the microbiome, immunity, and tissue integrity to understand their interplay in common disorders such as atopic dermatitis. In this Review, we explore microbiome shifts associated with cutaneous disorders with an eye toward how the microbiome can be mined to identify new therapeutic opportunities.

Authors

Tiffany C. Scharschmidt, Julia A. Segre

×

Figure 2

Methods to interrogate skin microbiome and avenues of downstream analysis.

Options: View larger image (or click on image) Download as PowerPoint
Methods to interrogate skin microbiome and avenues of downstream analysi...
Swabbing the skin surface with a mild detergent to lift off the outer dead layers of skin and release the associated microbes has become the accepted best method to sample the microbiome (171). While some microbes have deeper reservoirs within the skin tissue, for example, within deeply embedded pilosebaceous units, swabs are much more tolerable to research subjects than biopsies for repeatedly sampling of the skin microbiota. After extracting DNA directly from the clinical sample, bacterial and fungal members of a skin community are identified by amplifying and sequencing 16S rRNA and ITS1 marker genes, respectively. 16S rRNA primers used to characterize the gut bacteria community failed to amplify Cutibacterium, a stumbling block rectifiable by amplifying the more 5′ region of the 16S rRNA (171, 172). Methods to make a sequencing library from the low biomass of a skin swab DNA opened up the possibility to perform skin shotgun metagenomic sequencing. After subtracting the human reads, shotgun metagenomic sequencing provides multikingdom (bacteria, fungi, virus) as well as strain-level analyses (6). The skin’s low microbial biomass created some challenges associated with air and reagent contaminants that could be monitored and controlled for with appropriate negative controls. Culturing isolates and performing whole-genome sequencing provides validation for strain level predictions and importantly provides resources for performing functional studies. Skin surface-associated bacteria persist by lowering their replication rate and perhaps even appearing as “quiescent” (173). Finding C. acnes in both cultures and shotgun metagenomic samples obtained by swabbing oily skin surfaces suggests that these microbes transit to the skin surface with terminally differentiating keratinocytes.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts